Caris Life Sciences, Inc. Common Stock
$22.74
USD
Last updated on --.
24h volume7.79M
24h highest22.7630 USD
24h lowest18.8020 USD
24h Price movement+0.00%
CAI recent prices
24 Hours
+0.00%$0.00
30 days
+27.25%+$4.870
60 days
+34.08%+$5.780
90 days
+42.66%+$6.800
Key data
Previous close22.7400 USD
Market cap5.65B USD
Volume7.79M
P/E ratio53.760000
Dividend yield (TTM)0.00%
Dividend amount0.30000 USD
Next ex-dividend dateSep 9, 2021
Next payment dateSep 27, 2021
EPS diluted (TTM)0.37000 USD
Net income (FY)105.14M USD
Revenue (FY)989.61M USD
Last report dateAug 5, 2026
About Caris Life Sciences, Inc. Common Stock
HeadquartersIRVING
Employees (FY)1.85K
Revenue per employee (FY)536.08K USD
Net income per employee (FY)56.95K USD
Listed onNasdaq
CAI conversion tables
 |  |
|---|---|
| 0.5 CAI | 11.37 USD |
| 1 CAI | 22.74 USD |
| 5 CAI | 113.7 USD |
| 10 CAI | 227.4 USD |
| |
|---|---|
| 0.5 USD | 0.021988 CAI |
| 1 USD | 0.043975 CAI |
| 5 USD | 0.21988 CAI |
| 10 USD | 0.43975 CAI |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CAI is trading at $22.74, +0.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CAI stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CAI is currently trading at $22.74, +0.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CAI price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SERVICES-MEDICAL LABORATORIES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CAI's P/E ratio is currently 53.760000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CAI; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CAI's historical range and other companies in the SERVICES-MEDICAL LABORATORIES sector.
Caris Life Sciences, Inc. Common Stock's market cap is currently 5.65B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume7.79M
24h highest22.7630 USD
24h lowest18.8020 USD
24h Price movement+0.00%
Start trade with CAI Perpetual
Sign up to trade